SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Jul-24 12:18 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jul-24 | Payment of Exercise | 3,345 | $0.55 | $1,826.37 | (2%) 203.85K to 200.5K | |
03-Jul-24 12:18 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jul-24 | Option Exercise | 9,375 | -- | -- | 5% 194.47K to 203.85K | |
02-Apr-24 6:32 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Apr-24 | Payment of Exercise | 3,345 | $0.71 | $2,366.59 | (2%) 197.82K to 194.47K | |
02-Apr-24 6:32 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Apr-24 | Option Exercise | 9,375 | -- | -- | 5% 188.44K to 197.82K | |
03-Jan-24 4:02 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Payment of Exercise | 3,841 | $0.82 | $3,156.15 | (2%) 192.28K to 188.44K | |
03-Jan-24 4:02 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Option Exercise | 9,375 | -- | -- | 5% 182.91K to 192.28K | |
03-Oct-23 4:27 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Payment of Exercise | 3,241 | $0.66 | $2,145.54 | (2%) 186.15K to 182.91K | |
03-Oct-23 4:27 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Option Exercise | 9,375 | -- | -- | 5% 176.78K to 186.15K | |
02-Aug-23 5:57 PM View: | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 148,514 | $1.01 | $149,999.00 | 525% 28.26K to 176.78K | |
05-Jul-23 4:06 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Payment of Exercise | 3,241 | $1.04 | $3,370.64 | (12%) 28.0K to 24.76K | |
05-Jul-23 4:06 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Option Exercise | 9,375 | -- | -- | 50% 18.63K to 28.0K | |
04-Apr-23 8:18 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Payment of Exercise | 3,241 | $1.01 | $3,273.41 | (15%) 21.87K to 18.63K | |
04-Apr-23 8:18 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Option Exercise | 9,375 | -- | -- | 75% 12.49K to 21.87K | |
07-Sep-21 4:09 PM View: | Forte Biosciences, Inc. (FBRX) | 07-Sep-21 | Market Sale | 25,000 | $4.24 | $106,105.00 | (69%) 36.06K to 11.06K | |
30-Jun-20 8:07 PM View: | Forte Biosciences, Inc. (FBRX) | 29-Jun-20 | Market Purchase | 2,000 | $14.11 | $28,220.00 | 6% 34.06K to 36.06K | |
30-Jun-20 8:07 PM View: | Forte Biosciences, Inc. (FBRX) | 26-Jun-20 | Market Purchase | 4,700 | $14.52 | $68,225.20 | 16% 29.36K to 34.06K | |
21-Nov-19 4:05 PM View: | Krystal Biotech, Inc. (KRYS) | 19-Nov-19 | Option Exercise | 6,250 | $9.85 | $61,562.50 | 223% 2.8K to 9.05K | |
24-May-18 5:28 PM View: | Krystal Biotech, Inc. (KRYS) | 22-May-18 | Market Purchase | 2,800 | $10.75 | $30,100.00 | 100% 0 to 2.8K | 114% |
14-Aug-07 10:00 PM View: | Avanex Corp. (AVNX) | 30-Jun-07 | Option Exercise | 28,261 | $0.00 | $28.26 | 29% 98.49K to 126.75K | |
03-Apr-07 9:29 PM View: | Avanex Corp. (AVNX) | 31-Mar-07 | Option Exercise | 28,260 | $0.00 | $28.26 | 40% 70.23K to 98.5K | |
22-Mar-07 9:59 PM View: | Avanex Corp. (AVNX) | 21-Mar-07 | Grant | 10,715 | -- | -- | 18% 59.52K to 70.23K | |
04-Jan-07 9:12 PM View: | Avanex Corp. (AVNX) | 31-Dec-06 | Option Exercise | 28,260 | $0.00 | $28.26 | 90% 31.26K to 59.52K | |
04-Oct-06 3:16 PM View: | Avanex Corp. (AVNX) | 02-Oct-06 | Market Sale (Planned) | 28,261 | $1.65 | $46,630.60 | 942% 3.0K to 31.26K | (88%) |
03-Oct-06 9:44 PM View: | Avanex Corp. (AVNX) | 30-Sep-06 | Option Exercise | 28,261 | $0.00 | $28.26 | 100% 28.26K to 56.52K | |
03-Oct-06 9:44 PM View: | Avanex Corp. (AVNX) | 15-Aug-06 | Grant | 3,000 | $1.07 | $3,213.00 | 5% 56.52K to 59.52K | |
11-Jul-06 10:00 PM View: | Avanex Corp. (AVNX) | 30-Jun-06 | Option Exercise | 28,260 | $0.00 | $28.26 | 100% 0 to 28.26K | |
15-May-06 8:15 PM View: | Avanex Corp. (AVNX) | 11-May-06 | Market Sale | 16,208 | $1.99 | $32,253.90 | (100%) 16.21K to 0 | 90% |
04-Apr-06 9:59 PM View: | Avanex Corp. (AVNX) | 31-Mar-06 | Payment of Exercise | 12,053 | $3.15 | $37,966.90 | (43%) 28.26K to 16.21K | 94% |
04-Apr-06 9:59 PM View: | Avanex Corp. (AVNX) | 31-Mar-06 | Option Exercise | 28,261 | $0.00 | $28.26 | 100% 0 to 28.26K |